Back
Aquestive Therapeutics Stock Price Chart
Buy
51
AQST
Aquestive Therapeutics
Last Price:
3.10
Seasonality Move:
9.86%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AQST is experiencing selling pressure, which indicates risk of future bearish movement.
Aquestive Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.19 | Sell |
| 20-day SMA: | 3.51 | Sell |
| 50-day SMA: | 4.08 | Sell |
| 200-day SMA: | 2.58 | Buy |
| 8-day EMA: | 3.24 | Sell |
| 20-day EMA: | 3.46 | Sell |
| 50-day EMA: | 3.65 | Sell |
| 200-day EMA: | 2.87 | Buy |
Aquestive Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 39.25 | Sell |
| Chaikin Money Flow: | -758826 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.2 - 4.04) | Sell |
| Bollinger Bands (100): | (2.46 - 4.4) | Sell |
Aquestive Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Aquestive Therapeutics Stock
Is Aquestive Therapeutics Stock a Buy?
- Aquestive Therapeutics share price is 3.11 while AQST 8-day simple moving average is 3.19, which is a Sell signal.
- The stock price of AQST is 3.11 while Aquestive Therapeutics 20-day SMA is 3.51, which makes it a Sell.
- Aquestive Therapeutics 50-day simple moving average is 4.08 while AQST share price is 3.11, making it a Sell technically.
- AQST stock price is 3.11 and Aquestive Therapeutics 200-day simple moving average is 2.58, creating a Buy signal.
AQST Technical Analysis vs Fundamental Analysis
Buy
51
Aquestive Therapeutics (AQST)
is a Buy
Is Aquestive Therapeutics a Buy or a Sell?
-
Aquestive Therapeutics stock is rated a Buy
The current Aquestive Therapeutics [AQST] share price is $3.11. The Score for AQST is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Aquestive Therapeutics Stock Info
Market Cap:
283.13M
Price in USD:
3.11
Share Volume:
834.75K
Aquestive Therapeutics 52-Week Range
52-Week High:
6.23
52-Week Low:
1.25
Buy
51
Aquestive Therapeutics (AQST)
is a Buy
Aquestive Therapeutics Share Price Forecast
-
What is the Aquestive Therapeutics stock price today?
The Aquestive Therapeutics stock price is 3.11 USD today. -
Will AQST stock go up or go down?
Aquestive Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Aquestive Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aquestive Therapeutics is not overvalued.
Is Aquestive Therapeutics Stock a Buy?
- Aquestive Therapeutics share price is 3.11 while AQST 8-day exponential moving average is 3.24, which is a Sell signal.
- The stock price of AQST is 3.11 while Aquestive Therapeutics 20-day EMA is 3.46, which makes it a Sell.
- Aquestive Therapeutics 50-day exponential moving average is 3.65 while AQST share price is 3.11, making it a Sell technically.
- AQST stock price is 3.11 and Aquestive Therapeutics 200-day simple moving average is 2.87, creating a Buy signal.
Fundamental Analysis of Aquestive Therapeutics
Is Aquestive Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.03 per share.
Technical Analysis of Aquestive Therapeutics
Should I short Aquestive Therapeutics stock?
- AQST Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting Aquestive Therapeutics is a Sell
- Aquestive Therapeutics Relative Strength Index (RSI) is 39.25, which suggest Aquestive Therapeutics is oversold
- The Bollinger Bands (25) for Aquestive Therapeutics is (3.2 - 4.04), which suggest Aquestive Therapeutics is a Sell
- The Bollinger Bands (100) for Aquestive Therapeutics is (2.46 - 4.4), which suggest Aquestive Therapeutics is a Sell
* Aquestive Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.